Muscarinic acetylcholine receptor stimulation induces expression of the activity-regulated cytoskeleton-associated gene (ARC).
D000818:Animals; D015152:Blotting, Northern / Q000379:methods; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D045744:Cell Line, Tumor; D018678:Cholinergic Agents / Q000494:pharmacology; D055515:Cysteine-Rich Protein 61; D003598:Cytoskeletal Proteins; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics / Q000378:metabolism*; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics; D008297:Male; D018721:Muscarinic Agonists / Q000494:pharmacology; D009419:Nerve Tissue Proteins; D009447:Neuroblastoma; D010862:Pilocarpine / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D011976:Receptors, Muscarinic / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects; D013997:Time Factors
C501848:CCN1 protein, human; C501849:CCN1 protein, rat; D018678:Cholinergic Agents; D055515:Cysteine-Rich Protein 61; D003598:Cytoskeletal Proteins; D004791:Enzyme Inhibitors; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D018721:Muscarinic Agonists; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D011976:Receptors, Muscarinic; C092069:activity regulated cytoskeletal-associated protein; D010862:Pilocarpine